U.S. SENATORS KATIE BRITT, RICK SCOTT, KIRSTEN GILLIBRAND, COLLEAGUES URGE DRUG COUNTRY OF ORIGIN TRANSPARENCY TO PROTECT AMERICAN PATIENTS

WASHINGTON, Feb. 10 -- Sen. Katie Britt issued the following press release:

U.S. Senator Katie Britt (R-Ala.) joined Senators Rick Scott (R-Fla.), Kirsten Gillibrand (D-N.Y.), Chairman and Ranking Member of the Senate Committee on Aging respectively, along with Senators Ron Johnson (R-Wis.) and Tommy Tuberville (R-Ala.) in introducing the bipartisan Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings (CLEAR LABELS) Act. The bill would add country of origin labeling requirements to the U.S.'s prescription drug supply chain.

"Patients deserve transparency to make informed health care decisions. If someone is taking drugs from China and other foreign adversaries, they deserve to know," said Sen...